Nephrology

Filter

Sibeprenlimab Trial Shows Benefit in IgA Nephropathy - EMJ

UKKW 2026: Sibeprenlimab Reduces Proteinuria in IgA Nephropathy Trial

March 2026

Interim results from the Phase III VISIONARY trial show that sibeprenlimab significantly reduced proteinuria and improved disease biomarkers in patients with IgA nephropathy.

Sibeprenlimab Trial Shows Benefit in IgA Nephropathy - EMJ

UKKW 2026: Sibeprenlimab Reduces Proteinuria in IgA Nephropathy Trial

Interim results from the Phase III VISIONARY trial show that sibeprenlimab significantly reduced proteinuria and improved disease biomarkers in patients with IgA nephropathy.

eGFR equations vs measured GFR in CKD study - EMJ

UKKW 2026: CKD Study Questions Accuracy of Widely Used eGFR Equations

A large UK study finds commonly used eGFR equations may overestimate kidney function, potentially delaying chronic kidney disease diagnosis and treatment.

Individualising HDF Convection Volume in Dialysis Care - EMJ

UKKW 2026: Individualised Haemodiafiltration May Aid Clearance

A study suggests convection volume in haemodiafiltration may be tailored to patient weight and residual kidney function to optimise middle-molecule clearance.

UKKW 2026: AKI Recovery Threshold Predicts Kidney Failure Risk - EMJ

UKKW 2026: AKI Recovery Within 10% Predicts Long-Term Kidney Outcomes

A study of hospitalised patients with acute kidney injury shows that failing to recover creatinine within 10% of baseline at 3 months predicts worse 5-year kidney outcomes.

Review of the 62nd European Renal Association (ERA) Congress

‘Game Changers in Nephrology’ was the theme of the 62nd European Renal Association (ERA) Congress, held in Vienna, Austria…

Highlights from the 62nd ERA Congress

ERA Congress 2025 marked a pivotal moment in nephrology this year, bringing together over 9,000 global experts to explore transformative…

Game Changers in IgA Nephropathy

THE SESSION ‘Game Changers in IgA Nephropathy’, delivered at the ERA 2025 Congress, brought together leading experts to spotlight emerging…

ERA 2025 Interview: Rainer Oberbauer

I’ve been in the field for almost 30 years now. I started by chance after my postdoctoral training. I became interested in kidney…

Loading posts...